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The cellular interactions in the anti-p-azobenzenearsonate (ABA) 1 suppressor 
T  cell pathway, for the inhibition of ABA-specific delayed-type hypersensitivity 
and cytotoxic T  cell responses, are restricted by Igh-linked genes (reviewed in 
1). The inducer, Ts-1  (T suppressor cell), and the effector, Ts-3, suppressor T 
cells, and one of their factors (TsF1) bear the major crossreactive idiotypic (CRI) 
determinants recognized by rabbit antiidiotypic antibodies prepared by immu- 
nizing rabbits with purified anti-ABA from appropriate strains of mice (2, 3). 
The presence of these Ig idiotypic specificities on T  cells is not the result of 
the expression of Ig heavy chain  variable  region  genes in T  cells,  but rather 
reflects the degree to which the repertoire of these regulatory T cells is influenced 
by  the  Ig  idiotypes on  B  cells  during  their  differentiation  or  induction.  We 
therefore proposed (4) that clonal expansion of a B cell subpopulation bearing a 
particular idiotypic specificity stimulates the clonal expansion of corresponding 
antiidiotypic T  or B cells. These antiidiotypic T  or B cells, in turn, select and 
trigger the expansion of a population of idiotype-bearing T  cells. Therefore, the 
detection of Ig idiotypes on T  cells may merely reflect a  serological or confor- 
mational crossreactivity, and represent internal images of B cell idiotypic speci- 
ficities rather than a true genetic identity. 
This hypothesis is supported by findings indicating that certain T  cell activities 
appear to depend on B cells for their expression (reviewed in 5). These include 
idiotype-specific helper  T  cells  (6,  7),  isotype-specific helper  T  cells  (8),  and 
antigen-specific  proliferating  T  cells  (9,  10).  Moreover,  it  has  recently  been 
shown  (11)  that  B  cell-deficient  mice are  unable  to  produce one  of the  two 
chains  comprising the  T  cell-derived,  sheep  red  blood  cell-specific  inducer- 
suppressor factor. 
Taking advantage of our previous observations (1) of the expression of anti- 
CRI-defined idiotype by Ts-1  ceils and their factors (TsF1) in the ABA-system, 
we  studied  whether  the  presence  of  Ig-bearing  B  cells  is  required  for  the 
1  Abbreviations used in this paper:  ABA, p-azobenzenearsonate;  ABA-SC, ABA-coupled syngeneic 
spleen cells; anti-#, rabbit anti-mouse IgM; Con A, concanavalin A; CFA, complete Freund's  adjuvant; 
CRI, crossreactive idiotype; CTL, cytotoxic T lymphocyte; HBSS, Hank's balanced salt solution; Igh, 
Ig heavy chain gene loci; Ts, T suppressor cell; TsFl, first order suppressor T cell factor(s). 
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expression of idiotypes by ABA-specific Ts-1 and TsF1, and for the Igh-1  linked 
genetic restrictions  normally associated with  the activity of this  factor (4).  We 
reasoned that B cell-deficient mice, produced as a result of treatment with rabbit 
anti-mouse IgM antibodies (anti-u) starting within 24 h of birth (13,  14), would 
develop ABA-specific Ts-1  and TsF1 lacking the appropriate  idiotypic determi- 
nants  if, in fact, B ceils expressing idiotypes are ontogenically required  for the 
generation of idiotype-positive T  cells. We expected that ABA suppressor T  cells 
and  their  factors, when  taken  from mice developed without B cells, would no 
longer show Igh restrictions,  and would be active in all strains,  irrespective of 
their genotypes. In agreement with this prediction, TsFa obtained from anti-u- 
treated BALB/c mice gained the capacity of suppressing the DTH and cytotoxic 
T  lymphocyte (CTL) responses of normal C.AL-20 mice. Similarly, TsFl obtained 
from anti-#-treated  C.AL-20  mice  developed the  ability  to  suppress  BALB/c 
mice.  Moreover,  TsF1  from  anti-u-treated  C.AL-20  mice  was  found  not  to 
express the major CRI determinants normally associated with C.AL-20 TsF~ (4). 
However, to our surprise,  ABA-TsF~ from anti-u-treated  BALB/c or C.AL-20 
mice were not active in other strains,  such as H-2-identical  B10.D2  (12).  Fur- 
thermore,  while  ABA-TsF1  from  anti-u-treated  BALB/c  and  C.AL-20  mice 
reciprocally lost their Igh restrictions for each other,  they also lost their ability 
to suppress normal mice of their own respective strains. This study was designed 
to explore the parameters that normally limit the effects that Ig-bearing B cells 
have on the T  cell repertoire, as illustrated above. We made use of the relation- 
ships  that  have  been  shown  to exist between the  CRI  expressed  by anti-ABA 
antibodies of A or AL/N mice and BALB/c mice (15-18) to explain our earlier 
results. 
In the antibody response to ABA-KLH (keyhole limpet hemocyanin), all mice 
of the  A  or AL/N  strain,  including  allotype-congenic C.AL-20  mice,  produce 
anti-ABA antibodies that bear the CRI specificity CRI~A). In general, 20-70% of 
the  anti-ABA  population  carries  CRIcA  ) determinants  (15,  16).  In  addition,  a 
second  idiotypic family has  been  described,  which  comprises a  minor  portion 
(10-15%)  of the  anti-ABA  antibodies  produced  in  the  A  strain  of mice,  and 
which is serologicaily distinct from CRIiA ) (17,  18). It is of considerable interest 
that  this  minor  idiotype  in  the  A  strain  corresponds  to  the  major  idiotype 
associated with anti-ABA antibodies of BALB/c mice CRIme). 
The  availability  of  antiidiotypic  antibodies  against  CRI~A) and  CRI~c) has 
enabled  us to establish that  TsF1  obtained from anti-u-treated  C.AL-20  mice, 
functional in BALB/c but not in C.AL-20 mice, indeed bears the CRI~c) deter- 
minants.  And TsFI, obtained from anti-u-treated  BALB/c, suppresses C.AL-20 
but not BALB/c mice, and  expresses CRI~A) determinants.  The significance of 
these findings will be discussed with respect to the role of B cells in the generation 
of the suppressor T  cell repertoire. 
Materials and Methods 
Animals.  BALB/c (H-2 d,  Igh-1  a)  and  C.AL-20  (H-2  d,  Igh-1 a)  mice  were bred  and 
maintained in our colony in accordance with the guidelines of the Committee on Animals, 
of the Harvard Medical School, and those prepared by the Committee on Care and Use 
of Laboratory  Animals,  of the  Institute  of Laboratory  Animal  Resources,  National 
Research  Council  (Department  of Health  and  Human  Services  publication,  National 
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Preparation of Anti-u Antibodies,  and Treatment of Newborn Mice.  Anti-u were prepared 
by immunizing NZW rabbits with purified  MOPC  104E (),) or TEPC  183 (K) (Bionetics 
Laboratory Products,  Charleston,  SC) in  0.5-1  mg complete  Freund's  adjuvant (CFA) 
per immunization.  Hyperimmune antisera were pooled, absorbed with mouse red blood 
cells, and precipitated  twice with  50%  ammonium sulfate.  The final preparations  were 
then concentrated and dialyzed extensively with phosphate-buffered saline (pH 7.2). The 
amount of anti-u-specific antibody was quantitated by a quantitative precipitin test.  Each 
mouse received from 700 ug to 1 mg of rabbit anti-u per injection. Newborn mice were 
injected with 50 ul of anti-u (0.7-1  mg) i.p. within  24 h  three times per week (Monday, 
Wednesday, Friday), until they were sacrificed.  All experiments were carried out when 
animals reached the age of 6-7 wk. All mice were housed in cages with filters and acidified 
water (pH 2.8). 
Preparation  of Hapten-conjugated  Syngeneic Spleen  Cells.  The  diazonium  salt  of p- 
arsanilic acid (Kodak) was prepared as previously described (2). Briefly, a 40 mM solution 
of ABA-diazonium salt was prepared from arsanilic acid. The ABA solution was activated 
and conjugated to single-cell suspensions of erythrocyte-free spleen cells at a final concen- 
tration of 10 mM ABA. After washing twice in Hank's balanced salt solution (HBSS), the 
ABA-coupled spleen cells (ABA-SC) were used to prime for ABA-specific CTL in vivo. A 
total of 3 ×  I0  ~ viable ABA-SC were injected subcutaneously into two separate  sites on 
the dorsal flanks of mice. Each group consisted of at least two mice. 
In  Vitro Induction  of CTL.  7  d  after  subcutaneous  immunization,  spleen  cells  were 
prepared, and pooled for use as responder cells for in vitro culture. The culture conditions 
used to generate CTL have been described in detail elsewhere (4).  Briefly, 7 X 106 spleen 
cells  from primed  or suppressed  animals  were  cocultured  with  6  x  106  ABA-coupled 
irradiated syngeneic spleen cells in  16 mm Linbro tissue culture wells (Linbro Chemical 
Co., Hamden, CT) in a volume of 2 ml of medium per well. Culture medium consisted of 
RPMI  1640 supplemented  with  100  U/ml  Penicillin,  100 ug Streptomycin, 0.25 #g/ml 
Fungizone,  2  mM  glutamine,  5  x  10  -5  M  2-mercaptoethanol,  and  5-10%  preselected 
heat-inactivated fetal  calf serum.  Cultures  were incubated for 5  d  in 5%  CO~ at  37°C, 
with saturated humidity. 
Chromium-release Assay.  This assay has been described in detail previously (4). Briefly, 
3  ×  107, concanavalin A  (Con A)-induced blasts were labeled with 0.5-1.0 mCi of 5LCr 
for 90 min, washed, coupled with hapten as described above, and used as targets in the 
assay. Con A  blasts were prepared by culturing 4  X  106 spleen cells/ml with 2 t~g/ml of 
Con A  for 48 h  in RPMI  1640 medium, supplemented with serum, as described above. 
5,  Cytotoxicity was calculated on the basis of the  formula: percent specific  Cr release  -- 
51  51  ([  Cr release from targets in presence ofeffector cells] -  [spontaneous  Crrelease])/([max- 
imum ~Cr release in presence of detergent] -  [spontaneous release]).  The spontaneous 
release of Con A blast targets ranged from 20 to 30% in the 4 h assay. 
Preparation of Suppressor  T  Cell  Factor.  Normal  or anti-u-treated  mice were  given 
intravenous injections of 5 ×  107 ABA-SC, and irradiated (1,500 rad). 7 d later, the mice 
were  sacrificed,  and  the  spleens  teased  into  single-cell  suspensions.  Suppressor  factors 
were prepared using a snap-freezing and thawing method, as described (11). Briefly, 5 × 
10  s washed  spleen  cells  in  1 ml  of HBSS were subjected  to alternate  snap  freezing at 
-70°C  and  thawing  at  37°C.  This  was  repeated  four  times,  and  was  followed  by 
centrifugation at 10,000 g for 90 min. The supernatants were then frozen at -70 °C until 
use.  To  test  the  ability  of TsF  to  inhibit  ABA-specific CTL  response,  2  ×  10  v cell- 
equivalents/day of TsF were injected  intravenously into ABA-SC-primed normal mice, 
7  beginning at the day of immunization with 3 x  10  ABA-SC, and for five successive days. 
2 d after the last injection, the animals were killed and their spleens were removed to set 
up the CTL assay. 
Affinity  Chromatography of TsF.  Solid-phase immunoadsorbent columns were prepared 
and  characterized  as described  (2).  TsF  was fractionated  on  immunoadsorbents  in  the 
following manner: A  5-ml plastic column containing antibody-conjugated Sepharose 4 B 
(Pbarmacia  Fine  Chemicals,  Piscataway,  N  J)  was prepared  by using an  IgG fraction of 
anti-CRI antiserum.  Rabbit anti-CRI(A) antibodies were prepared by repeatedly injecting 
rabbits subcutaneously with specifically purified A/J anti-ABA antibodies in CFA. These SY ET AL.  1405 
antibodies were rendered specific for idiotypic determinants by repeated absorption with 
normal A/J Ig. Antiidiotypic antibodies against the BALB/c major idiotypic family, CRI(c), 
was prepared by immunizing rabbits with a monoclonal anti-ABA antibody, 36-60, which 
is the major idiotypic family in BALB/c mice, and represents a minor component in A/J 
mice; 36-60 is derived from A/J mice (18). These antibodies were kindly provided to us 
by Dr. M. Gelfter of Massachusetts Institute of Technology, Boston, MA. 
A control column was similarly prepared, using an IgG fraction of normal rabbit serum 
in place of the anti-CRI antiserum. The adsorption of the factor is carried out at 4°C by 
allowing 5 ×  10  s cell-equivalent of TsF in a  1 ml volume to enter the gel matrix. The 
TsF was then allowed to remain in the column at least 60 min at 4 ° C. The column was 
then washed with at least 5× its own void volume, using cold PBS (pH 7.2). Such effluents 
were termed filtrates. Materials that remained in the column were eluted with five bed- 
volumes  of a  glycine-HCl  buffer  (pH  2.8).  The  collected eluates  were  immediately 
neutralized to pH 7.0 with  1 N NaOH as the material emerged from the column. Both 
the filtrates and eluates were concentrated to the original volume by negative pressure 
dialysis  at  4°C,  and  were  thereafter frozen  at  -70°C.  Such  materials  were  thawed 
immediately before use. 
Results 
Serological  Characterization  of  TsF1 Obtained from  C.AL-20  and  BALB/c 
Mice.  Our previous work (1) has demonstrated that TsF1 obtained from C.AL- 
20 mice, bears the major CRI determinants that are serologically crossreactive 
with  those  present  in  anti-ABA  antibodies  from  appropriate  strains  of CRI(A) 
mice.  We  would  expect,  accordingly,  that  TsF1  from  normal  BALB/c  mice 
should bear the corresponding CRI(c) determinant normally associated with anti- 
ABA antibodies  of BALB/c mice.  Therefore, we investigated whether antiidi- 
otypic antibodies  prepared against  the CRI(c)determinant will  react with TsFl 
from normal BALB/c mice. 
ABA-specific  TsF  was  prepared  from  normal  BALB/c  and  C.AL-20  mice. 
These TsF were then passed through an anti-CRI(A) or anti-CRI(c) column. Both 
the filtrate (unbound) and the acid eluate (bound) were then tested on BALB/c 
or C.AL-20  mice,  respectively, for their ability to suppress  priming for ABA- 
specific CTL responses. The results of such an experiment are shown in Figs.  1 
and  2.  When  TsF1  obtained  from  normal  C.AL-20  was  passed  over an  anti- 
CRI(A)  column,  no suppressive activities could be found in the filtrate, and all 
the suppressive activity could be recovered in the acid eluate. In contrast, when 
this factor was passed through an anti-CRI(c) column, all the suppressor activity 
remained in  the  filtrate,  and  the  eluate was  devoid of any suppressor activity 
(Fig.  1).  On  the  other hand,  the  suppressor activity of normal  BALB/c TsFl, 
when passed through an anti-CRI(A) column, was found in the filtrate, not in the 
acid eluate (Fig. 2). This provides direct evidence that TsFl from BALB/c mice 
lacks CRIIA  ) specificities. When normal BALB/c TsF was passed through an anti- 
CRI(c) column (Fig.  2),  most of the suppressor activities could be recovered in 
the acid eluate. Nevertheless, there was significant suppressor activity that failed 
to bind to the anti-CRI(c) column. This observation differs significantly from our 
findings  with  C.AL-20  TsF~  and  anti-CRI(A)  immunoabsorbent  columns.  In 
C.AL-20  mice,  it  is  evident  that  most,  if not  all  of the  TsF~  activities can  be 
retained  by anti-CRI(A) columns.  The failure of anti-CRI(c) column  to bind all 
the BALB/c TsF1 is not due to over-saturation of the immunoadsorbent column, 
since repassage of the unbound fraction over the anti-CRI(c) column also failed 1406  T  CELL  DEVELOPMENT  IN  B  CELL-DEFICIENT  MICE 
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FIGURE  ].  Normal C.AL-20 TsF can he retained by anti-CR](A) but not anti-CR[(c) column. 
Normal  C.AL-20  TsF1  was prepared by intravenous injection  of 5  x  10; ABA-SC; 7  d  later 
TsF~ was prepared as described. 2 x  10  s cell-equivalents of TsF were passed through an anti- 
CRI(^) or anti-CRI(c) immunoabsorbent column. Both the unbound fraction (11) (filtrate) and 
the bound fraction (&) (eluate) were tested in immunized C.AL-20 mice. Control mice were 
normal C.AL-20 mice immunized subcutaneously with 3  ×  107 ABA-SC only (O).  TsF was 
given to the experimental groups, beginning on the day of immunization, for five successive 
days at 2 x  107 cell-equivalents/day in 0.2 ml volumes. 2 d after the last injection, spleen cells 
from each group were removed to set up ABA-specific CTL culture. ABA-CTL assays were 
done  5  d  later,  as described in  Materials and Methods.  Percent  specific killing represents 
killing of ABA-conjugated syngeneic Con A blasts minus killing of unconjugated blasts. 
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FIGURE 2.  Majority of BALB/c TsFl can be retained by anti-CRI(c) but not by anti-CRl(A) 
column.  The  experimental  protocols  used  in  these  experiments  were  exactly  identical  to 
experiments presented in  Fig.  1, except normal BALB/c TsFl  was used instead of normal 
C.AL-20 TsF1. (O) Control mice were normal BALB/c mice immunized subcutaneously with 
3  x  107 ABA-SC. (11) Animals treated with unbound (filtrate) fraction. (A) Animals treated 
with bound (eluate) fractions. 
to demonstrate any additional  binding (data not shown). From this experiment 
we can  conclude  that,  as expected,  normal  C.AL-20  TsF~  bears determinants 
that  crossreact  with  CRItA)  specificities,  and  does  not  crossreact  with  CRI(c) 
specificities. In contrast, most, but not all of the normal BALB/c TsF1 expresses 
determinants crossreactive with CRIIc),  but not with CRI(A). 
Igh Restriction  Specificities of BALB/c Factors  that Failed  to Bind  to Anti-CRItc) 
lmmunoabsorbent  Column.  Our observation that ABA-specific TsF1 from normal 
BALB/c mice appears  to  be idiotypically somewhat  more  heterogeneous  than 
C.AL-20 TsFI raised an important issue regarding the Igh restriction specificity 
of the fraction of normal BALB/c TsF~ that does not express CRI(c) determinants. 
It is possible that  the small fraction of BALB/c TsFx  that  was CRI(c)- may not 
be  Igh  restricted  in  its function.  Therefore,  we enriched  the  CRI(c)- TsF  by SY ET AL. 
TABLE  I 
Igh Restriction Specificity of CRI~c)-bearing and Non-CRItc)-bearing BALC/c 
TsF1 
1407 
Specific killing-*  at effector/tar- 
Strain  Treatment*  get ratios of: 
100:1  50:1  25:1 
BALB/c 
C.AL-20 
% 
--  40  32  19 
Anti-C  RI~c)-passed TsF ~: 
Filtrate  21  15  8 
Eluate  13  10  2 
--  57  40  28 
Anti-CRI~c)-passed TsF~: 
Filtrate  52  39  26 
Eluate  49  42  37 
Normal BALB/c or C.AL-20 were immunized subcutaneously with 3  ×  107  ABA- 
conjugated syngeneic spleen cells.  7  d  later,  spleen cells from control and treated 
animals were cultured in vitro for 5 d  in the presence of ABA-SC as stimulators for 
the generation of ABA-specific CTL response. 
* ABA-specific TsFI from BALB/c mice were passed over an anti-CRI~c) immunoabsor- 
bent column, as described in Materials and Methods. Both the unbound (filtrate) or 
bound (acid eluate) fractions were injected into BALB/c or C.AL-20 mice, beginning 
on the day of immunization, for five successive days at 2 x  l0  T cell-equivalents/day, 
in 0.2  ml  volumes. 2 d  after the last injections, spleen cells from each group were 
removed to set up ABA-specific CTL culture. 
* A standard 4-h 5aCt-release assay was done after 5 d in culture. Percent specific killing 
represents killing  on  ABA-conjugated syngeneic  Con  A  blasts,  minus  killing  on 
uncoupled Con A blasts. 
passing normal  BALB/c TsF1 over an anti-CRI~c)  column and assaying for the 
Igh restriction of the unbound TsF. The results of such an experiment are shown 
in  Table  I.  As can  be seen,  normal  BALB/c TsF1  can  be divided into  CRI~c)- 
bearing and non-CRI~c)-bearing fractions; both of these fractions are suppressive 
in normal  BALB/c mice.  More importantly,  both the non-CRItc)-bearing  and 
CRI~c)-bearing fractions remain  nonfunctional in C.AL-20 mice, indicating that 
even though some of BALB/c TsF~ may not express CRI~c) determinants,  they 
are still  Igh restricted in their function. 
TsFl Obtained from Anti-#-treated  C.AL-20 Mice Expressed CRI~c) but not CRI~a) 
Determinants.  Since TsF1  obtained from anti-#-treated  C.AL-20 mice inhibits 
the development of ABA-specific CTL responses in normal  BALB/c mice but 
not in C.AL-20 mice, we next examined whether these TsF~ bear CRI~c) speci- 
ficities. ABA-specific TsF~ was prepared from anti-t~-treated C.AL-20 mice. This 
TsFa was then passed through an anti-CRI~A) or an anti-CRI~c)  column. Both the 
filtrate and acid eluate were then tested in BALB/c mice. 
The results of a representative experiment are shown in Table II. As we have 
reported earlier (4), TsFl obtained from anti-~-treated C.AL-20 mice no longer 
expresses CRI~A) determinants.  Therefore,  when passed through  a  rabbit anti- 
CRI~A) column, the suppressor activities reside mainly in the filtrate,  not in the 
acid eluate.  In contrast,  the identical TsF~, when passed through an anti-CRI~c) 
column, yields a filtrate with minimal  suppressor activity; significant suppressor 1408  T  CELL  DEVELOPMENT  IN  B  CELL-DEFICIENT  MICE 
TABLE  II 
TsFL  from Anti-u-treated  C.AL-20 Mice Can Be Retained by Anti- 
CRI(c) Column but Not by Anti-CRI(a) Column 
Treatment* 
Specific killing* at effector/target 
ratios of: 
100:1  50:1  25:1 
% 
--  85  60  41 
Anti-CRI(A)-passed TsF1: 
Filtrate  41  40  18 
Eluate  82  52  37 
Anti-CRI(c)-passed TsFl: 
Filtrate  62  48  30 
Eluate  45  31  22 
Normal  BALB/c mice were  immunized subcutaneously  with  3  x  107 
ABA-conjugated syngeneic  spleen  cells.  7  d  later,  spleen  ceils  from 
controls and treated groups were cultured in vitro for 5 d in the presence 
of ABA-SC as  stimulators  for  the  generation  of ABA-specific CTL 
response. 
* TsF~  was  obtained  from  anti-u-treated  C.AL-20  mice  and  passed 
through either an anti-CRI(A)or anti-CRI(c)column. Both the filtrate and 
eluate from each column was tested in BALB/c mice, as described. 
* A standard 4-h ~Cr-release assay was done after 5 d in culture. Percent 
specific killing represents killing on ABA-conjugated syngeneic Con A 
blasts,  minus killing on uncoupled Con A blasts. 
8O 
60 
2O 
Anl/-CRI(A  )  Normal Rabbl119 
i  i  i  i  i  J 
I00 I  50:1  25 I  I00:1  50 I  25  1 
Effeclor/Taryet  Rob? 
AnI/-CRI(c  ) 
I  I  I 
100 I  50  I  251 
FIGURE  3.  ABA-specific TsF~ from anti-u-treated  BALB/c mice can  be retained  by anti- 
CRI(A) but not by anti-CRI(c) column. ABA-specific TsFI  was prepared  from anti-u-treated 
BALB/c mice, as described.  The  factor(s)  was  then  passed  through  an anti-CRl(a),  normal 
rabbit Ig, or anti-CRI(c) column. Both the filtrate and acid eluate were tested in normal C.AL- 
20 mice, as described in Materials and Methods, and in Fig. 1. (O) Control mice were normal 
C.AL-20 mice immunized subcutaneously  with 3  x  107 ABA-SC. (n) Animals treated  with 
unbound (filtrate) fractions. (I) Animals treated with bound (eluate) fractions. 
activity can  then  be recovered  in  the acid eluate.  This  experiment  suggests  that 
the reason  for the ability of ABA-specific TsF  from anti-/z-treated  C.AL-20  mice 
to work in BALB/c  is directly related to their acquisition of the CRI(c) specificities. 
TsFl Obtained from Anti-u-treated BALB/c Mice Express CRI(a) Determinants but 
Not CRI(c) Specificities.  Since anti-/z-treated  BALB/c  TsF  was shown  to suppress 
C.AL-20  mice,  we  wished  to  know  whether  TsF  from  anti-/z-treated  BALB/c SY ET AL.  1409 
mice acquires the capacity to express the CRIcA  ) determinants. Experiments were 
done using an identical protocol. ABA-specific TsF1 was prepared from anti-#- 
treated BALB/c mice. This TsF was then passed through an anti-CRI~A) or anti- 
CRI~c) column. Both the filtrate and acid eluate were then tested in C.AL-20 
mice. The  results of a  typical experiment are shown in  Fig.  3.  It  was clearly 
shown  that,  as  with  TsF~  obtained  from anti-#-treated  C.AL-20  mice, TsFI 
obtained from anti-u-treated BALB/c mice displays the opposite idiotypic spec- 
ificities normally associated with BALB/c TsF1. Anti-# BALB/c TsF~ expressed 
the CRI~A) specificities associated with normal C.AL-20 TsF1. None of the factors 
bound to the normal rabbit Ig control column, since all the suppressor activity 
was detected in the filtrate, and none in the acid eluate. 
Discussion 
The presence of Ig idiotypes on T  cells, and of Igh-controlled restrictions in 
the suppressor T  cell cascade led us to propose that these idiotypes and corre- 
sponding Igh restrictions they determine are the reflection of the influence that 
the  major  B  cell  idiotypes  impose  on  the  T  cell  repertoire  during  T  cell 
development or antigen-specific immune responses (4). Our observations, in the 
ABA-specific T  cell suppressor system, that the CRI on TsF1 were dependent on 
the presence of Ig-bearing B cells expressing these very same idiotypes was in 
agreement with our hypothesis and provided, in addition, the indication that the 
network theory of Jerne (19)  should be  extended to  the relationships  that  it 
imposes on the respective repertoires of T  cells and B cells. 
In the course of the experiments carried out with anti-#-treated mice, we were 
puzzled  by  the  findings  that  the  loss  of the  major  idiotype of ABA-specific 
antibodies of C.AL-20  mice CRItA) by the TsF1  from anti-#-treated C.AL-20 
mice  was  associated  with:  (a)  New  Igh  restrictions  that  favor  exclusively 
BALB/c mice, to the exclusion of other congeneic strains, expressing different 
Igh genes. (b) Loss of the ability to suppress normal C.AL-20 mice. 
We  reasoned  that  these  results,  in  addition  to  their  demonstration  of the 
influence of Ig idiotypes on the suppressor T  cell repertoire, were conditioned 
by the interesting reciprocal relationships that exist in the idiotypes of anti-ABA 
antibodies of A and C.AL-20 mice, and of BALB/c mice. A and C.AL-20 mice, 
which display CRI~A) as  their major idiotypes,  also display CRItc~ specificities, 
characteristic of BALB/c  mice,  on  a  minor population  of their  ABA-specific 
antibodies, and that BALB/c mice, which normally express the CRI~c) idiotype, 
can be induced, under certain circumstances, to express the CRI~A~ idiotype (20). 
We report that a  large fraction of the TsFI  from BALB/c mice display CRI~c~, 
even though a significant fraction, 15-40%, is CRI~c)-. 
The  failure  of our  anti-CRItc~  column  to  bind  all  of the  BALB/c  TsF1  is 
probably not due to the fact that the antiidiotypic antibodies used were prepared 
by immunizing rabbits with monoclonal anti-ABA antibodies (18), since a second 
anti-CRItc~  immunoabsorbent  column  prepared  with  rabbit  anti-CRItc~  anti- 
bodies,  which were generated by immunizing rabbits  with purified anti-ABA 
antibodies from  BALB/c mice (kindly provided by  Dr.  A.  Brown of St. Jude 
Children's  Research  Hospital,  Memphis,  TN),  also  revealed  the  presence  of 
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Moreover,  since none of the  BALB/c TsF can  be retained  by the anti-CRI(A) 
immunoabsorbent  column,  the  non-CRI(c)-bearing  TsF  does  not  bear  CRI(A) 
determinants  either.  Furthermore,  since both the CRI(c)-bearing and the non- 
CRI(c)-bearing TsF show similar restriction  specificity for BALB/c mice, these 
factors must play a role in the ABA-specific suppressor pathway in BALB/c mice. 
Our experiments have also shown that TsFx from anti-#-treated C.AL-20 mice 
not only acquired the capacity to work in BALB/c mice, but more importantly, 
also  expressed  the  CRI(c)  specificities.  Similarly,  TsF1  from  anti-u-treated 
BALB/c mice is functional in C.AL-20 mice, and bears the CRI(A) determinants. 
The  results  obtained  from  anti-#-treated  BALB/c mice deserve further  com- 
ment,  since almost all of the TsF~  prepared  from anti-u-treated  BALB/c mice 
can be retained by anti-CRI(A)  column. Therefore, we must conclude that both 
the CRI(c)-bearing and non-CRI(c)-bearing TsFl normally associated with normal 
BALB/c mice were replaced by CRI(A)-bearing TsF in anti-u-treated  mice. 
These  observations  suggest  that  the  effect  of anti-u  treatment  is  complex. 
Since <1% of Ig-bearing B cells can be detected in our anti-u-treated mice (data 
not shown), the effect of these B cells in determining T  cell idiotype specificities 
is expected to be minimal.  Yet, the removal of most B cells now enables a minor 
TsF~ idiotypic specificity to become dominant,  by a mechanism that remains to 
be elucidated.  It has been reported  by Kim and  her colleagues (21) that  even 
though no serum IgM can be detected in anti-u-treated mice, detectable amounts 
of total Ig, IgG1, and IgG2 in these mice were 1,000-fold,  100-fold, and 5,000- 
fold less,  respectively, than  those of control  mice.  These residual  Ig molecules 
may play a  role in  the alteration  of Igh restriction  patterns  in  our experiment 
model. However, it should be noted that in the previous studies (21), spleen cells 
from anti-u-treated  mice contained  2-5%  Ig  + B  cells, and  the serum  samples 
were pooled, not from individual  mice.  In  our anti-u-treated  mice,  the  B cell 
level  never  reached  higher  than  2%,  and  no  Ig  was detected  in  their  serum. 
Thus, it is not clear by what mechanisms T  cells in anti-u-treated  C.AL-20 mice 
acquire  CRI(c)  determinants,  and  T  cells  from  anti-u-treated  BALB/c  mice 
acquire CRI(A) specificities. It has been reported by Slaoui and his associates (20) 
that treatment of BALB/c mice, which normally do not express CRI(A) specifici- 
ties with monoclona] anti-CRI~A~ antibodies, causes them to express these deter- 
minants when immunized against ABA. More recently, it was found that,  while 
BALB/c mice normally are insensitive to the suppressor effect of TsFl obtained 
from  A/J  mice,  treatment  of BALB/c mice  with  anti-CRI(A)  monoclonal  anti- 
bodies rendered  them  susceptible to  the  suppressive  effect of TsF~  from  A/J 
mice (M.  Slaoui,  personal  communication).  Since proper  idiotypic and  antiidi- 
otypic interaction  is absolutely required for the completion of the ABA-specific 
suppressor  pathway,  we can  conclude  from  these experiments  that  the  CRI(A) 
idiotype is indeed present in  the potential  repertoire  of BALB/c mice, both in 
the  T  and  B  cell  compartment,  but  that  during  a  normal  humoral  or  cell- 
mediated  response  to  ABA,  these  CRI<A~-bearing  clones  remain  silent  or  sup- 
pressed.  This  dominant  trait  can  be  broken  either  by treatment  with  anti-u, 
starting  at  birth,  as  in  our  experiments,  or  by  treatment  with  monoclonal 
antibodies in adulthood. 
The mechanism responsible for the preferential expansion of CRItc~ clones at 
the expense of CRI(A) clones in normal  BALB/c mice is not clear. In the C.AL- SY ET AL.  1411 
90  mice, it is known that CRI(c)  specificities represent a  minor portion of the 
idiotypic families (10-15%), while the majority (20-70%) ofanti-ABA antibodies 
bear CRI(A) specificities. Therefore, in  C.AL-20  mice, in  contrast to  BALB/c 
mice, CRI(A) clones rather than CRI(c) clones are preferentially expanded. What- 
ever the mechanism responsible for the preferential clonal expansion of CRI(A) 
B cells in C.AL-20  mice, and of CRI(c)  B cells in BALB/c mice, based on our 
results, the development of idiotypic specificities on suppressor T  cells appears 
to parallel that in  B cells. Thus, the majority of the TsF~  from C.AL-20  mice 
bears CRI(A) determinants, and most, but not all of the TsF~ from BALB/c mice 
bear CRI(c) determinants. It is possible that TsF obtained from C.AL-20  mice 
contain a small portion that bears CRI(c), and that a minor fraction of BALB/c 
TsF expresses CRI(A) specificities, but due to limitations in the sensitivity of our 
in vivo assay, we may not be able to detect them. 
The exact mechanisms responsible for the dominance of one idiotypic family 
over another one in TsF repertoire is unknown, but it is clear that the establish- 
ment of a hierarchy in the expression of a particular idiotypic specificity in TsF 
results in the Igh restriction specificity of that TsF. It is possible that explanations 
that have been suggested for the phenomenon of idiotypic dominance in antibody 
responses  may  be  also  applicable  to  the  dominance of idiotypic  family TsF 
repertoire. These include affinity for antigen, clonal size, or regulatory mecha- 
nisms, either in the form of helper or suppressor T  cells (22-24). For example, 
in normal C.AL-20 mice, the presence of antiidiotypic helper T  cells specific for 
CRI(A) could promote the clonal expansion of CRItA)  + T  cells, or conversely, the 
presence of antiidiotypic TsF~ specific for CRI(c) in C.AL-20 mice could prevent 
the emergence of CRI(c)-bearing T  cells in these mice. If this is true, one could 
postulate a breakdown of the idiotypic hierarchy in anti-g-treated mice, resulting 
in the appearance of the minor idiotypic specificities over a major idiotypic family 
in  the  TsF~.  Nevertheless,  the  mechanisms  by  which  B  cells  influence  the 
hierarchy of the suppressor T  cell idiotypic family still remain a mystery. 
Summary 
Serological  analysis  of idiotypic  specificities present  in  azobenzenearsonate 
(ABA)-specific first-order suppressor  T  cell factors (TsF1) from C.AL-20  and 
BALB/c  mice revealed a  significant  difference between TsF  from  these  two 
strains of mice. The idiotypic composition of TsFI  from BALB/c mice appears 
to be more heterogeneous, and at least two different fractions can be readily 
identified. One bears the characteristic BALB/c-associated CRI(c) (crossreactive 
idiotype) determinants, and the other is non-CRI(c)-bearing. Analysis of ABA- 
specific TsF1  from animals lacking B cells uncovered a  fundamental change in 
the expression of their idiotypic specificities. TsF from rabbit anti-mouse IgM 
(anti-g)-treated C.AL-20 mice failed to express the characteristic CRI(A) deter- 
minants. Instead, they express CRI(c)  specificities. Similarly, TsF~  from anti-g- 
treated BALB/c mice did not express their characteristic CRI(c) specificities, but 
rather express CRI(A) determinants. These experiments provide strong evidence 
that the Igh restriction specificity of TsF is dictated by the particular idiotypic 
specificities expressed.  They also  clearly  demonstrate  that  B  cells  and  their 
products play an important role in  establishing the idiotypic composition and 
repertoire of suppressor T  cells. 1412  T  CELL  DEVELOPMENT  IN  B CELL-DEFICIENT MICE 
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